1. Home
  2. ZNTL vs AOUT Comparison

ZNTL vs AOUT Comparison

Compare ZNTL & AOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • AOUT
  • Stock Information
  • Founded
  • ZNTL 2014
  • AOUT 2020
  • Country
  • ZNTL United States
  • AOUT United States
  • Employees
  • ZNTL N/A
  • AOUT N/A
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • AOUT Ordnance And Accessories
  • Sector
  • ZNTL Health Care
  • AOUT Industrials
  • Exchange
  • ZNTL Nasdaq
  • AOUT Nasdaq
  • Market Cap
  • ZNTL 227.0M
  • AOUT 195.7M
  • IPO Year
  • ZNTL 2020
  • AOUT N/A
  • Fundamental
  • Price
  • ZNTL $2.25
  • AOUT $16.73
  • Analyst Decision
  • ZNTL Buy
  • AOUT Strong Buy
  • Analyst Count
  • ZNTL 8
  • AOUT 2
  • Target Price
  • ZNTL $10.50
  • AOUT $12.50
  • AVG Volume (30 Days)
  • ZNTL 1.6M
  • AOUT 75.3K
  • Earning Date
  • ZNTL 02-25-2025
  • AOUT 03-06-2025
  • Dividend Yield
  • ZNTL N/A
  • AOUT N/A
  • EPS Growth
  • ZNTL N/A
  • AOUT N/A
  • EPS
  • ZNTL N/A
  • AOUT N/A
  • Revenue
  • ZNTL $40,560,000.00
  • AOUT $201,598,000.00
  • Revenue This Year
  • ZNTL N/A
  • AOUT $5.63
  • Revenue Next Year
  • ZNTL N/A
  • AOUT $6.85
  • P/E Ratio
  • ZNTL N/A
  • AOUT N/A
  • Revenue Growth
  • ZNTL N/A
  • AOUT 3.66
  • 52 Week Low
  • ZNTL $2.16
  • AOUT $7.45
  • 52 Week High
  • ZNTL $18.07
  • AOUT $16.98
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 32.94
  • AOUT 68.63
  • Support Level
  • ZNTL $2.16
  • AOUT $14.68
  • Resistance Level
  • ZNTL $2.93
  • AOUT $16.73
  • Average True Range (ATR)
  • ZNTL 0.28
  • AOUT 0.87
  • MACD
  • ZNTL -0.07
  • AOUT -0.04
  • Stochastic Oscillator
  • ZNTL 7.69
  • AOUT 90.84

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

Share on Social Networks: